125 results on '"Konturek, S. J."'
Search Results
2. EXTRAGASTRIC DISORDERS AND H. PYLORI INFECTION. EPIDEMIOLOGICAL STUDY IN POLISH URBAN POPULATION
3. HELICOBACTER PYLORI (HP) INFECTION IN ROSACEA
4. HELICOBACTER PYLORI (HP) INDUCES THE RECURRENCE OF ACETIC ACID INDUCED CHRONIC ULCERATION IN RATS
5. EFFECT OF TRIPLE ERADICATION THERAPY ON ULCER HEALING IN MOUSE MODEL OF HELICOBACTER PYLORI (HP)-INFECTION
6. WATER EXTRACTS OF HELICOBACTER PYLORI (Hp) SUPPRESS THE EXPRESSION OF HISTAMINE DECARBOXYLASE (HDC) IN THE RAT GASTRIC MUCOSA
7. HELICOBACTER PYLORI (HP) EXPRESSING CAGA AND VACA DELAYS THE HEALING OF ISCHEMIA-REPERFUSION (I/R) INJURY; A NEW MODEL OF STUDYING HP-PATHOGENESIS
8. APOPTOSIS AS A KEY EVENT IN THE DELAY THE ULCER HEALING INDUCED BY WATER EXTRACTS (WE) OF HELICOBACTER PYLORI (HP)
9. EXPRESSION OF APOPTOSIS RELATED GENES UPON TREATMENT OF KATO III CELLS WITH HELICOBACTER PYLORI (HP) AND ITS EXTRACTS
10. CagA+ H. PYLORI(HP) STRAIN DELAYS GASTRIC ULCER HEALING IN MOUSE THROUGH INDUCTION OF APOPTOSIS
11. Interaction of nitric oxide (NO) and capsaicin-sensitive neurons with epidermal growth factor (EGF) in healing of stress-induced gastric lesions 26.08
12. Lipopolysaccharide derived from Helicobacter pylori (Hp-LPS) protects gastric mucosa against acute injury in rats by induction of cyclooxygenase-2 (COX-2) and endogenous prostaglandins 05.07
13. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori
14. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans
15. Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta sub 1
16. Oral Cavity as a Potential Source of Helicobacter pylori Gastric Reinfection
17. Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta 1.
18. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defence against subsequent exposure to various strong irritants in rats.
19. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.
20. Role of gastric blood flow, neutrophil infiltration, and mucosal cell proliferation in gastric adaptation to aspirin in the rat.
21. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation.
22. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate.
23. Cholecystokinin in the control of gastric acid secretion in man.
24. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.
25. Letters to the editor
26. Distribution and release of epidermal growth factor in man.
27. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
28. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
29. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
30. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism.
31. Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients.
32. Gastric acid and pancreatic polypeptide responses to modified sham feeding. Effects of truncal and parietal cell vagotomy.
33. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
34. Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin.
35. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
36. Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients.
37. Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans.
38. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.
39. Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins.
40. Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer.
41. Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor.
42. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.
43. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
44. Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation.
45. Comparison of intraduodenal and intravenous administration of amino acids on gastric secretion in healthy subjects and patients with duodenal ulcer.
46. Intestinal phase of gastric secretion in patients with duodenal ulcer.
47. Serum gastrin and gastric acid responses to meals at various pH levels in man.
48. Effect of secretin and jejunal acidification on gastric and pancreatic secretion in man.
49. Effect of acid infusion into various levels of the intestine on gastric and pancreatic secretion in the cat.
50. Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.